LDN Science :- LDNscience™ is a public information project of the MedInsight Research Institute. Whether you are a physician, scientist or patient, our goal is to provide you with thorough information about Low Dose Naltrexone, OGFand related therapies. Please join our newsletter subscribers to ensure that you are the first to know about the latest developments. To your health, The LDNscience™ Team
LDN Info :- “Low Dose Naltrexone (LDN) may well be the most important therapeutic breakthrough in over fifty years. It provides a new, safe and inexpensive method of medical treatment by mobilizing the natural defenses of one’s own immune system. LDN substantially reduces health care costs and improves treatment of a wide array of diseases. Unfortunately, because naltrexone has been without patent protection for many years, no pharmaceutical company will bear the expense of the large clinical trials necessary for FDA approval of LDN’s new special uses. It is now up to public institutions to seize the opportunity that LDN offers.”— David Gluck, MD
Low Dose Naltrexone The Low Dose Naltrexone (LDN) group is an announcement and discussion group for those interested in LDN, and who wish to be notified about updates to the Low Dose Naltrexone website (www.lowdosenaltrexone.org).
Naltrexone While Low Dose Naltrexone (LDN) therapy is most often started at 1.5 mg and increased every 2 weeks to 30 days by 1.5 mg to a dose of 3.0 or 4.5 mg, informally known as the "Bihari Protocol", we will be discussing all doses, HIGHER or LOWER on this list.
LDN Users Low-Dose Naltrexone holds great promise for the millions of people worldwide with autoimmune diseases or central nervous system disorders or who face a deadly cancer.
LDN&IBD This forum is for those who just want to focus on LDN’s use with IBD issues. It is essential to remember that none of the LDNandIBD’s members are a doctor, a dietitian, a medical professional and/or a therapist. For any health or medical issues consult with your trained health practitioner or Doctor. The advice and information that you’re receiving is to be discussed with your doctor.
LDN&Fibro This group is for people with Fibromyalgia who are either taking or contemplating taking Low Dose Naltrexone. Because of the recent promising trials at Stanford University in regard to Fibromyalgia pain and Low Dose Naltrexone, more people are trying LDN. This discussion group will be able to talk about not only how the medication works but also about how the results pertain specifically to people with Fibromyalgia. We will also welcome discussion pertaining to diet, suppliments and complementary medicine.
LDN&RA This group is especially for people with rheumatoid arthritis (RA), but anyone who would like to read about or discuss the experience of taking low dose naltrexone (ldn) for autoimmune disease is welcome.
LDN&HIV/Aids The LDN in HIVAIDS e-group is for those interested in use of low-dose naltrexone (LDN) in HIV+AIDS as carriers, those related to carriers, caretakers, health professionals or other helpers in the field.
Hepatitis Children and CAM_Alternatives This Group welcomes both ADULTS & those with CHILDREN with Hepatitis or liver disease (including Hep B, Hep C, AutoImmune Hep, Liver Cancer, Primary Sclerosing Cholangitis, etc.). We are not 'defined' by this illness. Instead, our goal is to be 'refined' into compassionate people who seek to share healthy, hopeful, and winning remedies with others!
LDN4Pets Information on the use of Low Dose Naltrexone in the treatment of dogs, cats, horses and other pets. Known by the acronym LDN, this is a "low dose" form of therapy utilizing the FDA approved drug Naltrexone for the "off label" treatment of immune related disorders. The mechanism of action appears to involve an immune modulating or balancing effect of various components of the immune system mediated through an effect on Endorphin levels.
LDN German Forum Die LDN (Low Dose Naltrexone) Gruppe soll ein Forum werden, ähnlich wie die englischsprachige Yahoo-Gruppe, zum Informations-/Erfahrungsaustausch über LDN.